Cigna Group CI
The Cigna Group®, together with its subsidiaries (either individually or collectively referred to as the "Company," "we," "us" or "our"), is a global health company.
The Cigna Group is a global health company committed to creating a better future for every individual and every community. Powered by our dedicated people and valued brands, we advance our mission to improve the health and vitality of those we serve by staying grounded in the needs of our customers and patients - delivering a personalized, transparent and affordable health care experience. We focus on leading the way to partner and innovate solutions for better health.
At The Cigna Group our global workforce of approximately 67,700 colleagues strives to fulfill our mission to improve the health and vitality of more than 185 million customer relationships in more than 30 markets and jurisdictions (as of December 31, 2025). We play an important role in the health care system, and the breadth and depth of our customer relationships - as well as our approximately 1.7 million relationships with health care providers, clinics and facilities - give us opportunities to drive positive change.
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $274.90B | $247.12B | $195.26B | $180.52B | $174.07B | $160.40B | $153.57B | $48.65B | $41.81B | $39.84B |
| Cost of revenue | $214.99B | $182.51B | $133.80B | $124.83B | $117.55B | $103.48B | $97.67B | $4.79B | $2.46B | $2.47B |
| Gross profit | $59.91B | $64.61B | $61.46B | $55.68B | $56.52B | $56.92B | $55.90B | $43.86B | $39.35B | $37.37B |
| SG&A | $14.62B | $14.84B | $14.82B | $13.17B | $13.01B | $14.07B | $14.05B | $11.93B | $10.03B | $9.79B |
| Operating income | $9.20B | $9.42B | $8.54B | $8.45B | $7.94B | $8.15B | $8.08B | $4.16B | $3.94B | $3.09B |
| Pre-tax income | $7.78B | $5.27B | $5.51B | $8.40B | $6.79B | $10.87B | $6.57B | $3.58B | $3.61B | $2.98B |
| Income tax | $1.49B | $1.49B | $141.0M | $1.61B | $1.37B | $2.38B | $1.45B | $935.0M | $1.37B | $1.14B |
| Net income | $5.96B | $3.43B | $5.16B | $6.78B | $5.42B | $8.49B | $5.12B | $2.65B | $2.23B | $1.84B |
| EPS, basic | 22.33 | 12.25 | 17.57 | 21.66 | 15.89 | 23.17 | 13.58 | 10.69 | 8.92 | 7.31 |
| EPS, diluted | 22.18 | 12.12 | 17.39 | 21.41 | 15.75 | 22.96 | 13.44 | 10.54 | 8.77 | 7.19 |
| Shares, diluted (wtd. avg.) | $268.6M | $283.2M | $296.9M | $313.1M | $341.0M | $368.4M | $379.8M | $250.2M | $255.1M | $259.6M |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $7.68B | $7.55B | $7.87B | $5.98B | $5.12B | $10.24B | $4.67B | $3.85B | $2.97B | $3.19B |
| Short-term investments | $1.06B | $665.0M | $925.0M | $905.0M | $920.0M | $1.33B | $937.0M | $2.04B | $2.14B | — |
| Receivables | $28.77B | $24.23B | $17.72B | $17.22B | $15.07B | $12.19B | $10.72B | $10.47B | $3.15B | — |
| Inventory | $7.34B | $6.69B | $5.64B | $4.78B | $3.72B | $3.17B | $2.66B | $2.82B | $228.0M | — |
| Total current assets | $47.81B | $48.87B | $37.35B | $30.12B | $36.13B | $27.80B | $29.84B | $20.43B | $9.31B | — |
| Property, plant and equipment | $3.65B | — | — | $3.77B | $3.69B | $4.21B | $4.42B | $4.56B | $1.56B | — |
| Goodwill | $44.92B | $44.37B | $44.26B | $45.81B | $45.81B | $44.65B | $44.60B | $44.51B | $6.16B | $5.98B |
| Other intangibles | $28.56B | $29.42B | $30.86B | $32.49B | $34.10B | $35.18B | $36.56B | $39.00B | $345.0M | — |
| Total assets | $157.92B | $155.88B | $152.76B | $143.88B | $154.89B | $155.45B | $155.77B | $153.23B | $61.76B | — |
| Accounts payable | $10.66B | $9.29B | $8.55B | $7.78B | $6.66B | $5.48B | $5.09B | $4.37B | $184.0M | — |
| Short-term debt | $592.0M | $3.04B | $2.77B | $2.99B | $2.54B | $3.37B | $5.51B | $2.96B | $131.0M | — |
| Total current liabilities | $56.34B | $57.98B | $48.72B | $41.23B | $43.57B | $36.02B | $40.14B | $31.89B | $11.01B | — |
| Total liabilities | $116.05B | $114.64B | $106.41B | $99.13B | $107.70B | $105.06B | $110.39B | $112.15B | $48.00B | — |
| Retained earnings | $47.87B | $43.52B | $41.65B | $37.94B | $32.59B | $28.57B | $20.16B | $15.09B | $15.80B | — |
| Total equity | $41.71B | $41.03B | $46.24B | $44.69B | $46.98B | $50.19B | $45.34B | $41.03B | $13.71B | $13.70B |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $9.60B | $10.36B | $11.81B | $8.66B | $7.19B | $10.35B | $9.48B | $3.77B | $4.09B | $4.03B |
| Depreciation and amortisation | $2.77B | $2.77B | $3.04B | $2.94B | $2.92B | $2.80B | $3.65B | $695.0M | $566.0M | $610.0M |
| Capital expenditure | — | — | — | — | — | — | $1.05B | $528.0M | $471.0M | $461.0M |
| Investing cash flow | -$4.41B | -$2.10B | -$5.17B | $3.10B | -$3.61B | $2.98B | -$734.0M | -$26.38B | -$1.70B | -$2.57B |
| Financing cash flow | -$6.42B | -$7.65B | -$4.29B | -$11.24B | -$8.21B | -$8.53B | -$7.19B | $23.52B | -$2.65B | -$225.0M |
| Dividends paid | $401.0M | $392.0M | $362.0M | $368.0M | $357.0M | $345.0M | $15.0M | — | — | — |
| Buybacks | $3.62B | $7.03B | $2.28B | $7.61B | $7.74B | $4.04B | $1.99B | $342.0M | $2.73B | $139.0M |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001739940-26-000006.
Others in SIC 6324
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| UNH | UNITEDHEALTH GROUP INC | $356.47B | 30.0x | 11.8% |
| ELV | Elevance Health, Inc. | $88.37B | 16.2x | 12.5% |
| HUM | HUMANA INC | $48.21B | 40.8x | 31.6% |
| CNC | CENTENE CORP | $33.12B | — | 20.0% |
| MOH | MOLINA HEALTHCARE, INC. | $10.48B | 22.5x | 11.7% |
| OSCR | Oscar Health, Inc. | $9.75B | — | 39.0% |
| ALHC | Alignment Healthcare, Inc. | $2.81B | — | 46.1% |
| CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | $2.23B | — | 40.3% |